Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation - Report - MDSpire

Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation

  • By

  • Jaymit Patel

  • July 10, 2026

  • 0 min

Share

Clinical Report: Evaluating Normal Tissue Complication Probability Models for Osteoradionecrosis of the Jaw

Background

Osteoradionecrosis (ORN) is a significant complication following radiotherapy for head and neck cancer, characterized by severe bone and soft tissue damage. The incidence of ORN ranges from 7-10%.

Data Highlights

No numerical data available in the source material.

Key Findings

  • The NTCP model by van Dijk et al. identified D30% and pre-RT dental extraction as key predictors of ORN.
  • The model achieved an AUC of 0.78 in the training cohort and 0.75 in the validation set.
  • The PREDMORN study corroborated these findings, adding V70Gy and smoking status as additional predictors.
  • Model calibration improved with a Brier score of 0.077 and Log Loss of 0.281 in external validation cohorts.
  • Limitations include insufficient cohort diversity and under-representation of oral health variables.

Clinical Implications

Clinicians should consider the identified predictors when assessing ORN risk in patients undergoing radiotherapy for head and neck cancer. Enhanced cohort diversity and comprehensive treatment characterizations are necessary for better model applicability.

Conclusion

The review highlights the advancements in NTCP modeling for ORN while underscoring the need for further research to enhance clinical implementation and generalizability.

Related Resources & Content

  1. ADA News, October JADA, 2022 -- Effect of dental intervention before radiotherapy in patients with head and neck cancer
  2. Precision of Jaw Computer-Aided Design Models Generated from Ultra-Low MDCT Doses Utilizing ASIR and MBIR Techniques
  3. The ASCO Post, December 2020 -- Risk for Osteonecrosis of the Jaw After Treatment With Zoledronic Acid for Metastatic Bone Disease
  4. The ASCO Post, September 2024 -- New Collaborative Guideline Highlights the Importance of Multidisciplinary Care for Patients With Osteoradionecrosis
  5. Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline - PubMed
  6. Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis
  7. Beyond the Dose-Volume Histogram: A Critical Appraisal of Normal Tissue Complication Probability Modelling for Osteoradionecrosis of the Jaw
  8. Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline - PubMed

Original Source(s)

Related Content